Incyte Reports 2021 Fourth Quarter and Year-End Financial Results, and Provides 2022 Financial Guidance and Updates on Key Clinical Programs
Go back to Incyte Reports 2021 Fourth Quarter and Year-End Financial Results, and Provides 2022 Financial Guidance and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.40 | 52 Week High | $118.49 | |||
| Open | $124.40 | 52 Week Low | $55.00 | |||
| Day High | $124.40 | P/E | N/A | |||
| Day Low | $124.40 | EPS | $-0.56 | |||
| Volume | 560 | |||||
